TrialScientific reports2025

Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial).

Saran Sukkamolsantiporn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.